Want to visit Europe? That's gonna cost you ?5

Want to visit Europe? That's gonna cost you ?5

Eurozone vs. EU: What's the difference? Planning a European holiday? Get ready for some extra paperwork. And a new fee. Foreign visitors who currently enjoy visa-free travel to the European Union may soon have to register online and pay €5 before visiting the region, according to a new proposal from the European Commission. The change → Read More

Want to visit Europe? That's gonna cost you ?5

Want to visit Europe? That's gonna cost you ?5

Eurozone vs. EU: What's the difference? Planning a European holiday? Get ready for some extra paperwork. And a new fee. Foreign visitors who currently enjoy visa-free travel to the European Union may soon have to register online and pay €5 before visiting the region, according to a new proposal from the European Commission. The change → Read More

Stratasys Earnings: 3D Printer Sales Drop 20%, Stock Plummets 12%

Stratasys Earnings: 3D Printer Sales Drop 20%, Stock Plummets 12%

Stratasys (NASDAQ:SSYS) reported its third-quarter 2016 earnings before the market opened on Tuesday. The diversified 3D printing company posted a year-over-year revenue decline of 6.2%, driven by a 20% drop in 3D printer sales. Adjusted earnings per share — the most important earnings metric — declined from $0.01 to nearly $0.00. In light of the weaker-than-expected results → Read More

BMW Directly Taking on Uber and Lyft

BMW Directly Taking on Uber and Lyft

BMW (NASDAQOTH:BAMXF) wants to be ready for a world where the concept of car ownership is changing. The company has already been slowly rolling out its ReachNow service, a variation on car-sharing, in various major cities in the United States. The program lets registered users pick up a car and then drive it for as → Read More

2 Stocks That Quadrupled Over the Past 5 Years

2 Stocks That Quadrupled Over the Past 5 Years

One great way to start building an investment watchlist is to look for stocks that have performed remarkably well in the recent past. The theory is that winning businesses tend to keep on winning, so a stock that has already put up huge gains should continue to rise, if the underlying reasons for the company's → Read More

Procter & Gamble Co.'s Plan to Save $10 Billion

Procter & Gamble Co.'s Plan to Save $10 Billion

Many things went wrong for consumer goods giant Procter & Gamble (NYSE:PG) this past year. Fiscal 2016 marked its second straight year of decelerating sales growth as it lost market share in key product categories. P&G also underperformed its own profit target, with core earnings declining 2%. Yet the company blew past management's long-run targets → Read More

Why smartphone owners can't tell if their data is being sent to China

Why smartphone owners can't tell if their data is being sent to China

Watch a hacked ATM spew cash Smartphones sold in the U.S. have been secretly collecting user data and sending it to servers in Shanghai. The findings, announced this week by security firm Kryptowire, have raised questions about how users can keep the secrets stored on their smartphones from being siphoned away without their knowledge. Most → Read More

Why smartphone owners can't tell if their data is being sent to China

Why smartphone owners can't tell if their data is being sent to China

Watch a hacked ATM spew cash Smartphones sold in the U.S. have been secretly collecting user data and sending it to servers in Shanghai. The findings, announced this week by security firm Kryptowire, have raised questions about how users can keep the secrets stored on their smartphones from being siphoned away without their knowledge. Most → Read More

Marijuana Mania Grips the Nation As Voters Overwhelmingly Approve Legalization

Marijuana Mania Grips the Nation As Voters Overwhelmingly Approve Legalization

American voters delivered a decisive win for marijuana advocates on Nov. 8. Pro-pot propositions passed in eight of nine states last Tuesday, with four states, including California, voting to create recreational marijuana markets, and another four states passing medical marijuana laws. The approvals set the stage for accelerating growth in what's already a fast-moving market, → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.